Preparation and characterization of marine sponge collagen nanoparticles and employment for the transdermal delivery of 17β-estradiol-hemihydrate SCNPs for dermal delivery of estradiol

Drug Development and Industrial Pharmacy

Volumn 35, Issue 9, 2009, Pages 1035-1042

  Nicklas, Martina ^a   Schatton, Wolfgang ^a   Heinemann, Sascha ^b   Hanke, Thomas ^b   Kreuter, Jrg ^c  

^a KliniPharm GmbH   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Estradiol hemlhydrate; Hormone replacement therapy; Marine sponge collagen; Nanoparticles; Skin penetration enchancers

Indexed keywords

COLLAGEN; ESTRADIOL; ESTRADIOL VALERATE; GYNOKADIN; NANOPARTICLE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; ATOMIC FORCE MICROSCOPY; CHONDROSIA RENIFORMIS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG SALIVA LEVEL; HORMONE SUBSTITUTION; HUMAN; HYDROGEL; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; POSTMENOPAUSE; SALIVA; SPONGE (PORIFERA);

ABSORPTIOMETRY, PHOTON; ADMINISTRATION, CUTANEOUS; AGED; ANIMALS; BIOLOGICAL AVAILABILITY; COLLAGEN; DIALYSIS; DRUG CARRIERS; ELECTROCHEMISTRY; ESTRADIOL; EXCIPIENTS; FEMALE; HUMANS; HYDROGELS; MICROSCOPY, ATOMIC FORCE; MIDDLE AGED; NANOPARTICLES; PARTICLE SIZE; PORIFERA; SALIVA; THERMODYNAMICS;

EID: 70350694423     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902755213     Document Type: Article

References (30)

1. Kreuter J. (1994). Drug targeting with nanoparticles. Eur J Drug Metab Pharmacokinet, 19(3):253-256
2. Kreuter J. (1996). Nanoparticles and microparticles for drug and vaccine delivery. J Anat, 189(Pt 3):503-505 (Pubitemid 27011002)
3. Alonso MJ. (2004). Nanomedicines for overcoming biological barriers. Biomed Pharmacother, 58:168-172
4. Liu Y, Lü WL, Zhang Q. (2006). Recent advanced in liposomes and nanoparticles as drug carriers for drug delivery. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 28(4):583-589
5. Friess W. (1998). Collagen-biomaterial for drug delivery. Eur J Pharm Biopharm, 45(2):113-136
6. Kleinmann G, Larson S, Hunter B, Stevens S, Mamalis N, Olson RJ. (2007). Collagen shileds as a drug delivery system for fourthgeneration fluoroquinolones. Ophthalmologica, 221(1):51-56
7. Aishwarya S, Mahalakshmi S, Sehgal PK. (2008). Collagencoated polycaprolactone microparticles as a controlled drug delivery system. J Microencapsul, 7:1-9.
8. Takezawa T, Takeuchi T, Nitani A, Takayama Y, Kino-Oka M, Taya M, et al. (2007). Collagen vitrigel membrane useful for paracrine assays in vitro and drug delivery systems in vivo. J Biotechnol, 131(1):76-83.
9. Rössler B, Kreuter J, Ross G. (1994). Effect of collagen microparticles on the stability of retinol and its absorption into hairless mouse skin in vitro. Pharmazie, 49:175-179
10. Swatschek D, Schatton W, Müller WEG, Kreuter J. (2002). Microparticles derived from marine sponge collagen (SCMPs): Preparation characterization and suitability for dermal delivery of all-trans Retinol. Eur J Pharm Biopharm, 54:125-133
11. Swatschek D, Schatton W, Müller WEG, Kreuter J. (2000). Maritime sponge collagen: Isolation, characterization and suitability for microparticle-preparation. Arch Pharm Pharm Med Chem, 333(1):31.
12. Swatschek D, Schatton W, Kellermann J, Müller WEG, Kreuter J. (2002). Marine sponge collagen: Isolation, characterization and effects on the skin parameters surface-pH, moisture and sebum. Eur J Pharm Biopharm, 53(1):107-113
13. Garrone R, Huc A, Junqua S. (1975). Fine structure and physiocochemical studies on the collagen of the marine sponge Chondrosia reniformis Nardo. J Ultrastruct Res, 52(2):261-275
14. Heinemann S, Ehrlich H, Douglas T, Heinemann C, Worch H, Schatton W, et al. (2007). Ultrastructural studies on the collagen of the marine sponge Chondrosia reniformis Nardo. Biomacromolecules, 8(11):3452-3457
15. De Lignieres B, Basdevant A, Thomas G, Thalabard JC, Mercier- Bodard C, Conard J et al. (1986). Biological effects of estradiol-17 beta in postmenopausal women: Oral versus transdermal administration. J Clin Endocrinol Metab, 62:536-541
16. Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. (1997). Effects of oral and transdermal estrogen/ progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. Arterioscler Thromb Vasc Biol, 17:3071-3078
17. Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, et al. (2001). Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost, 85:619-625
18. Vongpatanasin W, Tuncel M, Wang Z, Arbiyue D, Mehrad B, Jialal I. (2003). Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol, 41:1358-1363
19. Schatton W, Schatton M, Swatschek D, Müller WEG, Kreuter J. (2007). Method for isolating collagen from marine sponges and producing nanoparticulate collagen, and the use thereof. European Patent no.1 259 120 B1, 35.
20. Horcas I, Fernandez R, Gomez-Rodriguez JM, Colchero J, Gomez-Herrero J, Baro AM. (2007). WSXM: A software for scanning probe microscopy and a tool for nanotechnology. Rev Sci Instrum, 2007;78(1):013705-1-013705-13708
21. European Pharmacopoeia. (2005). 5th ed., monograph 0821. Deutscher Apotheker Verlag: Stuttgart; 2087-2088
22. Kivlighan KT, Granger DA, Schwartz EB. (2005). Blood contamination and the measurement of salivary progesterone and estradiol. Horm Behav, 47(3):367-370
23. Kirschbaum C, Read GF, Hellhammer DH. (1992). Assessment of hormones and drugs in saliva in biobehavioral research. Seattle, Toronto, Bern, Göttingen: Hogrefe & Huber.
24. Lu Y, Bentley GR, Gann PH, Hodges KR, Chatterton RT. (1999). Salivary estradiol and progesterone levels in conception and nonconception cycles in women: Evaluation of a new assay for salivary estradiol. Fertil Steril, 71:863-868
25. Malamud D, Tabak L, eds. (1993). Saliva as a diagnostic fluid. Ann NY Acad Sci, 694:1-348.
26. Worthman CM, Stalling JF, Hofman LF. (1990). Sensitive salivary estradiol assay for monitoring ovarian function. Clin Chem, 36:1769-1773
27. Rössler B, Kreuter J, Scherer D. (1995). Collagen microparticles: preparation and properties. J Microencapsul, 12:49-57.
28. Berthold A, Cremer K, Kreuter J. (1998). Collagen microparticles: Carriers for glucocorticoids. Eur J Pharm Biopharm, 45:23-29
29. Blacker C, Brion N, Caulin F, Mayolle C, Reginster JY, Regnard A, et al. (1996). Plasma concentration of estradiol after transdermal administration of Systen® 50 (Evorel® ) or Menorest® . Clin Drug Invest, 11:339-346 (Pubitemid 26182729)
30. Järvinen A, Bäckström A-C, Elfström C, Viitanen A. (2001). Comparative absorption and variability in absorption of estradiol from a transdermal gel and a novel matrix-type transdermal patch. Maturitas, 38:189-196